Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 2057-2065

  Marshall, Lindsay J ^a   Ramdin, Lara S P ^b   Brooks, Teresa ^c   DPhil, Peter Charlton ^c   Shute, Janis K ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c Cantab Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CHEMOATTRACTANT; HEPARAN SULFATE; INTERLEUKIN 8; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SYNDECAN 1;

ARTICLE; BINDING SITE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL TRANSENDOTHELIAL MIGRATION; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE;

EID: 0042134798     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.2057     Document Type: Article

References (50)

1. Wagner, J. G., and R. A. Roth. 2000. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 52:349.
2. Huber, A. R., S. L. Kunkel, R. F. Todd, and S. J. Weiss. 1991. Regulation of transendothelial migration by endogenous interleukin-8. Science 254:99.
3. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385.
4. Gimbrone, M. A., M. S. Obin, A. F. Brock, E. A. Luis, P. E. Hass, C. A. Hebert, Y. K. Kip, D. W. Leung, D. G. Lowe, W. J. Kohr, et al. 1989. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interaction. Science 246:1601.
5. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13:291.
6. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17.
7. Tanaka, Y., D. H. Adams, and S. Shaw. 1993. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol. Today 14:111.
8. Hoogewerf, A. J., G. S. V. Kuschert, A. E. I. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. C. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570.
9. Kuschert, G. S. V., F. Coulin, C. A. Power, A. E. I. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. C. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959.
10. Rot, A., E. Hub, J. Middleton, F. Pons, C. Rabeck, K. Thierer, J. Wintle, B. Wolff, M. Zsak, and P. Dukor. 1996. Some aspects of IL-8 pathophysiology. III. Chemokine interaction with endothelial cells. J. Leukocyte Biol. 59:39.
11. Bernfield, M., M. Gotte, P. W. Park, O. Reizes, M. L. Fitzgerald, J. Linceum, and M. Zako. 1999. Functions of cell surface heparan sulphate proteoglycans. Annu. Rev. Biochem. 68:729.
12. Rosenberg, R. D., N. W. Schworak, J. Liu, J. J. Schwartz, and L. Zhang. 1997. Heparan sulphate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J. Clin. Invest. 99:2062.
13. Kainulainen, V., H. Wang, C. Schick, and M. Bernfield. 1998. Syndecans, heparan sulphate proteoglycans, maintain the proteolytic balance of acute wound fluid. J. Biol. Chem. 273:11563.
14. Fitzgerald, M. L., Z. Wang, P. W. Park, G. Murphy, and M. Bernfield. 2000. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 148:811.
15. Subramanian, S. V., M. L. Fitzgerald, and M. Bernfield. 1997. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 272:14713.
16. Woessner, J. F. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145.
17. Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lemaitre, P. Tipping, A. Drew, Y. Eeckhout, S. Shapiro, F. Lupu, and D. Collen. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439.
18. Berkenpas, M. B., D. A. Lawrence, and D. Ginsburg. 1995. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J. 14:2969.
19. Nilsson, K., S. Rosen, and P. Friberger. 1987. A new kit for the determination of tissue plasminogen activator and its inhibitor in blood. Fibrinolysis 1:163.
20. David, G., X. M. Bai, B. van der Schueren, J.-J. Cassiman, and H. van den Berghe. 1991. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119:961.
21. 2-macroglobulin. Clin. Exp. Allergy 28:616.
22. Samanta, A. K., J. J. Oppenheim, and K. Matsushima. 1990. Interleukin-8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J. Biol. Chem. 265:183.
23. Smart, S. J., and T. B. Casale. 1994. TNFα-induced transendothelial neutrophil migration is IL-8 dependent. Am. J. Physiol. 266:L238.
24. Bittleman, D. B., and T. B. Casale. 1995. Interleukin-8 mediates interleukin-1α-induced neutrophil transcellular migration. Am. J. Respir. Cell Mol. Biol. 13:323.
25. Schleef, R. R., M. P. Bevilacqua, M. Sawdey, M. A. Gimbrone, and D. J. Loskutoff. 1988. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 263:5797.
26. Smart, S. J., and T. B. Casale. 1993. Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:489.
27. Sprengers, E. D., and C. Kluft. 1987. Plasminogen activator inhibitors. Blood 69:381.
28. Mignatti, P., and D. B. Rifkin. 1996. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117.
29. Sprengers, E. D., J. W. N. Akkerman, and B. G. Jansen. 1986. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood. Thromb. Haemostasis 55:325.
30. Mousa, S. A., M. Forsythe, and T. M. Reilly. 1996. Platelet-endothelial cell interactions in mediating the release of plasminogen activator inhibitor-1. Biochem. Arch. 12:43.
31. Plow, E. F., and L. A. Miles. 1990. Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ. Dev. 32:293.
32. Schleef, R. R., D. J. Loskutoff, and T. J. Podor. 1991. Immunoelectron microscopic localization of type-1 plasminogen activator inhibitor on the surface of activated endothelial cells. J. Cell Biol. 113:1413.
33. Levin, E. G., and L. Santell. 1987. Association of plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of endothelial cells. J. Cell Biol. 105:2543.
34. Spillman, D., D. Witt, and U. Lindahl. 1998. Defining the interleukin-8 binding domain of heparan sulfate. J. Biol. Chem. 273:15487.
35. Furie, M. B., B. L. Naprstek, and S. C. Silverstein. 1987. Migration of neutrophils across monolayers of cultured microvascular endothelial cells: an in vitro model of leukocyte extravasation. J. Cell Sci. 88:161.
36. Delclaux, C., C. Delacourt, M.-P. d'Ortho, V. Boyer, C. Lafuma, and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14:288.
37. Mackarel, A. J., D. C. Cottell, K. J. Russell, M. X. Fitzgerald, and C. M. O'Connor. 1999. Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am. J. Respir. Cell Mol. Biol. 20:1209.
38. Allport, J. R., H. T. Ding, A. Ager, D. A. Steeber, T. F. Tedder, and F. W. Luscinskas. 1997. L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. J. Immunol. 158-4365.
39. Huber, A. R., and S. J. Weiss. 1989. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J. Clin. Invest. 83:1122.
40. Ulfman, L. H., D. P. H. Joosten, J. A. M. van der Linden, J. W. J. Lammers, J. J. Zwaginga, and L. Koenderman. 2001. IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells. J. Immunol. 166:588.
41. Ferland, C., M. Guilbert, F. Davoine, N. Flamand, J. Chakir, and M. Laviolette. 2001. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. J. Leukocyte Biol. 69:772.
42. Stefansson, S., C. C. Haudenschild, and D. A. Lawrence. 1998. Beyond fibrinolysis: the role of plasminogen activator inhibitor-1 and vitronectin in vascular wound healing. Trends Cardiovasc. Med. 8:175.
43. Chapman, H. A. 1997. Plasminogen activators, integrins and the co-ordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:714.
44. Bajou, K., R. D. Gerard, V. Masson, N. Brunner, C. Holst-Hansen, M. Skobe, N. E. Fusenig, P. Carmeliet, D. Collen, and J. M. Foidart. 1998. Absence of host plasminogen activator inhibitor-1 prevents cancer invasion and vascularization. Nat. Med 4:923.
45. Kato, M., H. Wang, V. Kainulainen, M. L. Fitzgerald, S. Ledbetter, D. M. Omitz, and M. Bemfield. 1998. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med. 4:691.
46. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439.
47. Eitzman, D. T., R. D. McCoy, X. Zheng, W. P. Fay, T. Shen, D. Ginsburg, and R. H. Simon. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-I gene. J. Clin. Invest. 97:232.
48. Oh, C. K., B. Ariue, R. F. Alban, B. Shaw, and S. H. Cho. 2002. PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem. Biophys. Res. Commun. 294:1155.
49. Cho, S. H. O., I. P. Hall, A. Wheatley, J. Dewar, D. Abraha, J. Delmundo, and C. K. Oh. 2001. Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene in the development of asthma. J. Allergy Clin. Immunol. 108:212.
50. Charlton, P. A., R. W. Faint, F. Bent, J. Bryans, I. Chicarelli-Robinson, I. Mackie, S. Machin, and P. Bevan. 1996. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb. Haemostasis 76:808.